Drug Trial Radar · NCT01946984
Diclofenac vs. Placebo in a Randomized Double Blind Controlled Trial in Post ERCP Pancreatitis
Last checked: Nov 20, 2026Latest source record: Sep 20, 2013 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
182
Actual
Start
Jun 2012
Primary completion
Jun 2013
Study completion Jun 2013
Sponsor
- Lead sponsor
- Specialized Arab HospitalAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Sep 20, 2013
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Prevention
- Who can join
- All sexes, from 16 years, up to 90 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
1. The most common complication of endoscopic retrograde cholangio-pancreaticography (ERCP) is pancreatitis. 2. Several studies showed that non-steroidal anti-inflammatory drugs (NSAIDs) can prevent the post ERCP pancreatitis, the investigators used diclofenac vs placebo. 3. The effect of diclofenac in prevention of that complication, was measured by the number of patients who developed pancreatitis, and compare it with the placebo. 4. The investigators collected 199 patients, 17 excluded, 182 completed the study, all of them underwent the intervention called "ERCP", and randomized to have either Diclofenac or Placebo before the procedure.
Conditions
- Post-ERCP Acute Pancreatitis.
Interventions
ERCPProcedure
endoscopy, retrograde cholangio-pancreaticography.
Diclofenac hydroxyethylpyrrolidineDrug
Normal SalineDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- prevention of pancreatitis,Time frame: within a week after procedure
Locations
1 site in 1 country. Site status is shown where the registry gives one.
SAH hospital
Nablus, West Bank, Palestinian Territories
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.